[N:1]1([C:6]2[CH:11]=[CH:10][C:9]([CH2:12][C@@H:13]([NH:17]C(=O)OC(C)(C)C)[C:14]([NH2:16])=[O:15])=[CH:8][CH:7]=2)[CH:5]=[CH:4][N:3]=[CH:2]1.CC[NH+](CC)CC.CC[NH+](CC)CC.C([O-])([O-])=O>Cl.O1CCOCC1>[N:1]1([C:6]2[CH:7]=[CH:8][C:9]([CH2:12][C@@H:13]([NH2:17])[C:14]([NH2:16])=[O:15])=[CH:10][CH:11]=2)[CH:5]=[CH:4][N:3]=[CH:2]1A solution of ((R)-tert-butyl 3-(4-(1H-imidazol-1-yl)phenyl)-1-amino-1-oxopropan-2-ylcarbamate (250 mg, 0.757 mmol) in 4M HCl in dioxane (4 mL) and 6N HCl (4 mL) was stirred at room temperature for 30 min. It was then concentrated in vacuo. The residue was dissolved in MeOH (10 mL), MP-carbonate resin (1.00 g, ca. 3 mmol/g, 3.00 mmol) was added. After swirling and standing for 2 h, the resin was filtered off. The filtrate was concentrated in vacuo to give (R)-3-(4-(1H-imidazol-1-yl)phenyl)-2-aminopropanamide as free base (100 mg).